Goadsby PJ, Reuter U, Hallstr&#246, m Y, et al. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017, 377(22):2123-2132. doi: 10.1056/NEJMoa1705848.

Articles

---

June 5th 2019

Study Summary: STRIVE Subgroup Analysis - Efficacy and Safety of Erenumab in Patients With Prior Preventive Treatment Failure

Goadsby PJ, Reuter U, Hallstr&#246, m Y, et al. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017, 377(22):2123-2132. doi: 10.1056/NEJMoa1705848.

---

May 9th 2018

Study Summary: STRIVE

Goadsby PJ, Reuter U, Hallstr&#246, m Y, et al. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017, 377(22):2123-2132. doi: 10.1056/NEJMoa1705848.

Latest Updated Articles

Published: August 18th 2025 | Updated: August 25th 2025

Conditional Economic Incentives Could Be Effective in Improving Adherence to Long-Acting PrEP in Transgender Adults

Published: August 19th 2025 | Updated: August 22nd 2025

Semaglutide Not Associated With Increased Risk of Eye Disorders

Published: June 6th 2025 | Updated: August 18th 2025

Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?

Published: June 27th 2025 | Updated: July 1st 2025

Report Reveals Mounting Burdens of Drug Shortages on US Health System

Published: February 20th 2025 | Updated: February 21st 2025

Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP

Published: January 16th 2025 | Updated: January 29th 2025

FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases